We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi and GlaxoSmithKline (GSK) have secured a $2.1 billion U.S. government contract to develop and produce 100 million doses of their COVID-19 vaccine candidate. Read More
Sanofi and GlaxoSmithKline have reached a deal with the British government that will secure up to 60 million doses of the drugmakers’ experimental COVID-19 vaccine for the UK. Read More
Eastman Kodak has landed a $765 million government loan to manufacture drug starting materials and active pharmaceutical ingredients in the U.S. Read More
Indivior has agreed to fork over $600 million in criminal and civil penalties and have a subsidiary plead guilty to making false statements to promote its opioid addiction treatment Suboxone film. Read More
Maryland-based Emergent BioSolutions has secured a $174 million contract with AstraZeneca (AZ) for large-scale manufacturing of drug substances for the UK company’s COVID-19 vaccine. Read More
Maryland-based Novavax has signed an agreement with Fujifilm Diosynth Biotechnologies to manufacture the bulk drug substance for Novavax’s COVID-19 vaccine candidate NVX-CoV2373. Read More